Research advances in nano-drug delivery system in liver cancer treatment
10.3969/j.issn.1001-5256.2022.08.037
- VernacularTitle:纳米载药系统在肝癌治疗中的研究进展
- Author:
Miaodong WANG
1
;
Zeshan CHEN
1
;
Peichun PENG
1
;
Xin DENG
2
Author Information
1. Graduate School, Guangxi University of Chinese Medicine, Nanning 530000, China
2. School of Basic Medical Sciences, Guangxi University of Chinese Medicine, Nanning 530000, China
- Publication Type:Reviews
- Keywords:
Liver Neoplasms;
Nano Drug Delivery System;
Therapeutics
- From:
Journal of Clinical Hepatology
2022;38(8):1906-1912
- CountryChina
- Language:Chinese
-
Abstract:
Traditional surgical resection, radiotherapy, and chemotherapy still play a dominant role in the treatment of liver cancer; however, their application in liver cancer patients is often limited by the toxic and side effects, unstable efficacy, and unclear targets of chemotherapeutic drugs. Therefore, in order to improve the efficacy of drugs in the treatment of liver cancer, nanomedicine, which has been developed in the biomedical field in recent years, has attracted more and more attention. Nano-drug delivery system has been gradually applied in clinical research for its advantages of low toxicity, wide bioavailability, controllable drug release, and good stability. This article focuses on the latest research advances in nano-drug delivery system in the treatment of liver cancer.
